HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures.

Frank van BuurenSven KreickmannDieter HorstkotteTanja KottmannKlaus Peter Mellwig

Published in: Clinical research in cardiology supplements (2013)

HELP is a safe, comfortable, and highly effective treatment in which adverse events are rare. It can reduce the burden of atherosclerosis, with no myocardial infarction and a low coronary intervention rate in our patients.

Keyphrases

cardiovascular disease
ejection fraction
end stage renal disease
heart failure
newly diagnosed
coronary artery disease
coronary artery
type diabetes
prognostic factors
cardiovascular events
left ventricular
aortic stenosis
atrial fibrillation
combination therapy